<?xml version='1.0' encoding='utf-8'?>
<document id="24961584"><sentence text="Da-Chaihu-Tang alters the pharmacokinetics of nifedipine in rats and a treatment regimen to avoid this."><entity charOffset="46-56" id="DDI-PubMed.24961584.s1.e0" text="nifedipine" /></sentence><sentence text="To investigate the influence of co-administrated Da-Chaihu-Tang (DCT; a traditional Chinese formulation) on the pharmacokinetics of nifedipine, as well as the safe optimal dosing interval to avoid the adverse interactions"><entity charOffset="132-142" id="DDI-PubMed.24961584.s2.e0" text="nifedipine" /></sentence><sentence text="" /><sentence text="A single dose of DCT was administered with nifedipine simultaneously, 2 h before, 30 min before or 30 min after nifedipine administration"><entity charOffset="43-53" id="DDI-PubMed.24961584.s4.e0" text="nifedipine" /><entity charOffset="112-122" id="DDI-PubMed.24961584.s4.e1" text="nifedipine" /><pair ddi="false" e1="DDI-PubMed.24961584.s4.e0" e2="DDI-PubMed.24961584.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24961584.s4.e0" e2="DDI-PubMed.24961584.s4.e1" /></sentence><sentence text=" Pharmacokinetics of nifedipine with or without DCT were compared"><entity charOffset="21-31" id="DDI-PubMed.24961584.s5.e0" text="nifedipine" /></sentence><sentence text=" The influences of DCT on nifedipine intestinal mucosal and hepatic metabolism were studied by using rat in-vitro everted jejunal sac model and hepatic microsomes"><entity charOffset="19-22" id="DDI-PubMed.24961584.s6.e0" text="DCT" /><entity charOffset="26-36" id="DDI-PubMed.24961584.s6.e1" text="nifedipine" /><pair ddi="false" e1="DDI-PubMed.24961584.s6.e0" e2="DDI-PubMed.24961584.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24961584.s6.e0" e2="DDI-PubMed.24961584.s6.e1" /></sentence><sentence text="" /><sentence text="A simultaneous co-administration of DCT significantly increased the area under concentration-time curve from time zero to infinity (AUC0-inf ) of nifedipine"><entity charOffset="146-156" id="DDI-PubMed.24961584.s8.e0" text="nifedipine" /><entity charOffset="36-45" id="DDI-PubMed.24961584.s8.e1" text="DCT" /><pair ddi="false" e1="DDI-PubMed.24961584.s8.e1" e2="DDI-PubMed.24961584.s8.e1" /><pair ddi="false" e1="DDI-PubMed.24961584.s8.e1" e2="DDI-PubMed.24961584.s8.e0" /></sentence><sentence text=" In-vitro mechanism investigations revealed that DCT inhibited both the intestinal and the hepatic metabolism of nifedipine"><entity charOffset="113-123" id="DDI-PubMed.24961584.s9.e0" text="nifedipine" /><entity charOffset="49-58" id="DDI-PubMed.24961584.s9.e1" text="DCT" /><pair ddi="false" e1="DDI-PubMed.24961584.s9.e1" e2="DDI-PubMed.24961584.s9.e1" /><pair ddi="false" e1="DDI-PubMed.24961584.s9.e1" e2="DDI-PubMed.24961584.s9.e0" /></sentence><sentence text=" Further study on the optimal dosing interval for nifedipine and DCT revealed that administration of DCT 30 min before or after nifedipine did not significantly change the AUC of nifedipine"><entity charOffset="50-60" id="DDI-PubMed.24961584.s10.e0" text="nifedipine" /><entity charOffset="128-138" id="DDI-PubMed.24961584.s10.e1" text="nifedipine" /><entity charOffset="179-189" id="DDI-PubMed.24961584.s10.e2" text="nifedipine" /><entity charOffset="65-74" id="DDI-PubMed.24961584.s10.e3" text="DCT" /><entity charOffset="101-110" id="DDI-PubMed.24961584.s10.e4" text="DCT" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e0" e2="DDI-PubMed.24961584.s10.e0" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e0" e2="DDI-PubMed.24961584.s10.e3" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e0" e2="DDI-PubMed.24961584.s10.e4" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e0" e2="DDI-PubMed.24961584.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e0" e2="DDI-PubMed.24961584.s10.e2" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e3" e2="DDI-PubMed.24961584.s10.e3" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e3" e2="DDI-PubMed.24961584.s10.e4" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e3" e2="DDI-PubMed.24961584.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e3" e2="DDI-PubMed.24961584.s10.e2" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e4" e2="DDI-PubMed.24961584.s10.e4" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e4" e2="DDI-PubMed.24961584.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e4" e2="DDI-PubMed.24961584.s10.e2" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e1" e2="DDI-PubMed.24961584.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24961584.s10.e1" e2="DDI-PubMed.24961584.s10.e2" /></sentence><sentence text="" /><sentence text="The bioavailability of nifedipine is significantly increased by a simultaneous oral co-administration of DCT"><entity charOffset="23-33" id="DDI-PubMed.24961584.s12.e0" text="nifedipine" /><entity charOffset="105-114" id="DDI-PubMed.24961584.s12.e1" text="DCT" /><pair ddi="false" e1="DDI-PubMed.24961584.s12.e0" e2="DDI-PubMed.24961584.s12.e0" /><pair ddi="false" e1="DDI-PubMed.24961584.s12.e0" e2="DDI-PubMed.24961584.s12.e1" /></sentence><sentence text=" This increase is caused by the inhibitory effect of DCT on both the intestinal mucosal and the hepatic metabolism of nifedipine"><entity charOffset="118-128" id="DDI-PubMed.24961584.s13.e0" text="nifedipine" /><entity charOffset="53-62" id="DDI-PubMed.24961584.s13.e1" text="DCT" /><pair ddi="false" e1="DDI-PubMed.24961584.s13.e1" e2="DDI-PubMed.24961584.s13.e1" /><pair ddi="false" e1="DDI-PubMed.24961584.s13.e1" e2="DDI-PubMed.24961584.s13.e0" /></sentence><sentence text=" The dose interval between DCT and nifedipine needs to be set for over 30 min to avoid such drug-drug interactions"><entity charOffset="35-45" id="DDI-PubMed.24961584.s14.e0" text="nifedipine" /><entity charOffset="27-36" id="DDI-PubMed.24961584.s14.e1" text="DCT" /><pair ddi="false" e1="DDI-PubMed.24961584.s14.e1" e2="DDI-PubMed.24961584.s14.e1" /><pair ddi="false" e1="DDI-PubMed.24961584.s14.e1" e2="DDI-PubMed.24961584.s14.e0" /></sentence><sentence text="" /></document>